Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L3 pseudogene 4 (RPL3P4) is a processed pseudogene in the human genome, named for its sequence similarity to the functional gene encoding ribosomal protein L3, a core component of the 60S ribosomal subunit. RPL3P4 does not code for a functional protein. It is one of multiple such processed pseudogenes dispersed throughout the genome, which arise as by-products of gene duplication and retrotransposition events and generally do not have known biological roles or direct disease associations[1][2]. RPL3P4 is not a protein-coding gene; it is a pseudogene, meaning it resembles a gene but is non-functional and does not produce a protein product[1][2]. The functional analog is Ribosomal protein L3 (*RPL3*), which is part of the ribosome, but RPL3P4 itself does not contribute to ribosome structure or function[1][2][5]. Pseudogenes are not considered druggable or therapeutic targets, nor are they established biomarkers. No drugs, mechanisms of action, disease associations, or safety considerations are listed for this pseudogene, as it lacks direct biological or therapeutic relevance in the same manner as protein-coding genes. There is nothing to suggest RPL3P4 is therapeutically actionable, has a physiologically relevant function, or plays any disease role. Instead, it is best considered a nonfunctional genomic artifact[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L3 pseudogene 4 (RPL3P4).